Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,525 total articles
RPM International reported a blowout Q3 with $1.608B in revenue and record adjusted EBIT, validating a thesis that steady maintenance-driven end markets plus margin expansion will carry results near-term. At a $13.4B market cap and P/E ~20, the stock offers asymmetric upside if RPM sustains operating leverage and free cash flow conversion. This is …
Nebius (NBIS) combines large-scale GPU infrastructure, an AI-centric cloud platform, and data/edge brands that make it a direct beneficiary of the shift toward open-source AI. With a $55.3B market cap, visible revenue momentum and major enterprise contracts, the stock looks actionable on a disciplined long plan: entry $220.00, stop $190.00, target …
The Trade Desk (TTD) has been repriced on slowing top-line growth, a public agency dispute and executive churn. At a $9.17B market cap, no debt, and roughly $842M in free cash flow, the stock offers a risk-reward setup for investors willing to accept a lower-growth profile. We outline an actionable long trade with entry, stop and target, plus the c…
LendingTree is trading at single-digit multiples despite strong profitability, free cash flow and accelerated revenue growth. We like a long position at $45.36 with a $65 target over the next 180 trading days, and a $40 stop. The trade banks on valuation rerating, stabilization under CEO Scott Peyree and continued demand across home, consumer and i…
Nano Labs is a small, Hangzhou-based fabless chip designer focused on high-throughput and vision computing chips and distributed computing solutions. The stock is trading at a market cap near $46M with a PE of ~2.1 and PB ~0.43. Management has signaled intent to pursue North America AI infrastructure via a recent MoU, and the CEO has been a materia…
Fortuna Mining (FSM) is showing steady production, aggressive capital returns, and visible project optionality from its Diamba Sud asset in Senegal. With Q2 2026 production of 72,217 gold equivalent ounces and a 73% expansion of indicated resources at Diamba Sud, the stock looks positioned for a mid-term re-rating if project permitting and FID prog…
Acrivon Therapeutics (ACRV) sits at roughly a $84M market cap with an enterprise value near $50M, negative EPS (-$1.81) and steep free cash flow burn (-$66.3M). The company’s AP3 precision platform and a 62.5% OncoSignature-positive ORR in endometrial cancer are real positives, but the stock is vulnerable to dilution, trial execution risk and senti…
Infleqtion (INFQ) is a pure-play neutral-atom quantum company with recent government funding, defense contracts, and a healthy cash bedside. The stock pulled back to $11.17 after a post-funding run; fundamentals show deep liquidity and early commercialization. We upgrade our stance to Buy and outline a tactical swing trade for traders looking to ca…
Harvia offers investors exposure to a niche, high-margin consumer durable market with a resilient replacement flywheel and international expansion optionality. I view the risk/reward as favorable from current levels and propose a tactical long with a clear entry, stop and two-stage target plan tied to visible operational catalysts.
Willdan Group (WLDN) combines energy consulting and engineering services with a growing focus on grid modernization and AI-enabled energy solutions. The stock trades well below its 52-week high, shows oversold technicals and meaningful short interest versus a small float. Fundamentals - rising margins, positive EPS and solid free cash flow - suppor…
Weave Communications is transitioning pricing toward a consumption model and layering AI-driven features after the trueLark acquisition. With Q2 2025 revenue momentum, a modest market cap of ~$552M, and reasonable leverage, the stock looks set for a swing trade that captures re-rating if usage and ARPU climb. Trade plan provided with clear entry, s…
Domino's is down from its highs but still generates strong free cash flow, a healthy FCF yield and a dividend that cushions downside. We take a constructive mid-term view: buy at $300, stop at $282, target $350 over the next 45 trading days, betting on margin resilience, buybacks and improving sentiment after leadership transition noise.
Nextdoor is repositioning from a local social network to an AI-first neighborhood commerce platform. With a sub-$1B market cap, positive momentum in self-serve ad growth, and a unique verified identity graph, NXDR offers asymmetric upside if management executes on agentic AI monetization — but execution risk and a thin revenue base keep this a spec…
XPeng's June deliveries of 40,126 units and the Mona L03 SUV pre-sale announcement have re-energized investor sentiment. Fundamentals remain mixed, but recent sales momentum, improving technicals and elevated short interest create a favorable trade setup for a mid-term long with clear risk controls.
Alliance Resource Partners (ARLP) combines a cyclical coal business with meaningful royalty streams and strong free cash flow. At $24.58 today, the partnership yields roughly 9.8%, trades at a reasonable EV/EBITDA of 5.9 and carries low leverage. This trade idea targets a move back toward the 52-week high as coal demand rebalances and royalties mon…
Ponce Financial Group (PDLB) has rallied toward its 52-week high but the bank's improving earnings, regulatory wins, and still-reasonable valuation leave room for upside. We lay out a mid-term trade: enter at $19.90, stop at $18.25, target $24.00, with a 45-trading-day horizon driven by continued loan and deposit growth plus potential re-rating cat…
Karman (KRMN) is printing strong top-line growth and visibility into 2026 thanks to a $1B+ backlog and a buoyant defense cycle. The stock trades at premium multiples (P/E ~220, EV/Sales ~14), so an actionable long makes sense only with disciplined sizing, a clear stop and a mid-term time box. We lay out an entry at $50.00, a target of $65.00 and a …
Ooma (OOMA) is a small-cap cloud communications and smart security company trading near $20 with free cash flow and analyst optimism supporting upside. The valuation is modest on an enterprise basis while technicals and short-interest dynamics favor a swing trade. This idea lays out an entry, stop and target with a clear horizon and risk framework.
Similarweb is showing early signs that large LLM contracts and AI-driven product upgrades can re-accelerate topline and drive higher-value enterprise deals. The stock is cheap on a market-cap-to-guidance basis, technicals show momentum and short interest remains manageable. This trade targets a recovery toward prior highs if management converts LLM…
Silence (SLN) trades at a market cap of ~$429M and is a candidate for a meaningful re-rating if upcoming polycythemia vera (PV) data and continued RNA-platform progress validate the program. We initiate a long trade with a clear entry, stop and a long-term target that still sits well below many analyst 12-month averages.
Disney trades near its 52‑week low despite healthy free cash flow, low leverage and multiple near‑term catalysts (summer parks, new theatrical releases). At roughly $95.73 today, the stock looks like a mid‑term buy: entry $95.73, stop $91.50, target $110.00 over ~45 trading days.
SanDisk is reinventing itself from a pure NAND supplier into a vertically integrated, product-led storage company aimed at enterprise AI, edge compute and automotive. The market is still treating it like a commodity play. This trade buys that the re-rating of margins and recurring-software revenue is coming into the price over the next 180 trading …
BridgeBio's recent clinical readouts and a $1 billion preferred equity infusion materially de-risk the company's near-term cash runway while multiple NDA submissions and Attruby's strong long-term mortality signal justify a
Evercore's upgrade to outperform and a cleaner balance sheet give Occidental (OXY) a credible path to re-rating. Free cash flow, modest leverage and strong EV/EBITDA metrics argue for further analyst upgrades and short-covering. This is a tactical long trade for the mid term (45 trading days) with clear risk controls.
Cybin (HELP) is a clinical-stage psychedelic drug developer trading at $6.86 with a $425M market cap. Technical momentum, a shrinking 52-week range, and concentrated short interest create a favorable asymmetric setup ahead of upcoming clinical catalysts. This trade idea targets a mid-term swing (45 trading days) long entry on a pullback, with clear…
